-Tsutomu Iwamoto Researcher Activity Profile

Research Author Detailed Information 

Tsutomu Iwamoto Publication Rate By Year

Tsutomu Iwamoto has published 1 paper(s) in 2006, 4 paper(s) in 2007, 2 paper(s) in 2008, for a total of 7 research publications in total.

Tsutomu T Iwamoto Author Information

LAST NAME: iwamoto

FIRST NAME: tsutomu

INITIALS: T

AFFILIATION:

Papers

Tsutomu Iwamoto's Publication Record

1. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy. Year Published: 2007
Department of Oral and Maxillofacial Surgery, Unit of Translational Medicine, Course of Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, Japan. syana@nagasaki-u.ac.jp
2. TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding. Year Published: 2007
Laboratory of Cell and Developmental Biology, NIDCR, National Institutes of Health, Bethesda, Maryland 20892-4370, USA.
3. Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation. Year Published: 2006
Division of Oral and Maxillofacial Surgery, Department of Development and Reconstructive Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588.
4. TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding. Year Published: 2007
Laboratory of Cell and Developmental Biology, NIDCR, National Institutes of Health, Bethesda, Maryland 20892-4370, USA.
5. Neurotrophic Factor Neurotrophin-4 Regulates Ameloblastin Expression via Full-length TrkB. Year Published: 2008
Section of Pediatric Dentistry and Orthodontics, Division of Oral Health, Growth, and Development, Faculty of Dental Science, Kyushu University, Fukuoka 812-8582, Japan, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8521, Japan.
6. Neurotrophic factor neurotrophin-4 regulates ameloblastin expression via full-length TrkB. Year Published: 2008
Section of Pediatric Dentistry, Kyushu University, Fukuoka 812-8582, Japan.
7. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy. Year Published: 2007
Department of Oral and Maxillofacial Surgery, Unit of Translational Medicine, Course of Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, Japan. syana@nagasaki-u.ac.jp